Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBRAM.L Regulatory News (BRAM)

  • There is currently no data for BRAM

Form 8.3 - Brammer PLC

4 Jan 2017 13:45

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Invesco Limited
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Brammer Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

03 January 2017
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO: AL Robin Limited

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: GB0001195089

Ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 4,370,204 3.37%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

4,370,204 3.37%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1©, copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
Ordinary Sale 447,322 1.66 GBP

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 04 January 2017
Contact name: Philippa Holmes
Telephone number: 01491 417 477

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170104005857/en/

Copyright Business Wire 2017

Date   Source Headline
1st May 20134:02 pmRNSDirector/PDMR Shareholding
26th Apr 20134:03 pmRNSDirector/PDMR Shareholding
19th Apr 20133:29 pmRNSDirector/PDMR Shareholding
8th Apr 20134:49 pmRNSDirector/PDMR Shareholding
26th Mar 201312:13 pmRNSDirector/PDMR Shareholding
20th Mar 20134:41 pmRNSDirector/PDMR Shareholding
15th Mar 20132:03 pmRNSDirector/PDMR Shareholding
21st Feb 201310:09 amRNSDirector/PDMR Shareholding
19th Feb 20137:00 amRNSPreliminary Results
30th Jan 201311:19 amRNSHolding(s) in Company
18th Jan 20139:15 amRNSNotice of Results
14th Jan 201312:26 pmRNSBlocklisting Interim Review
10th Jan 20133:08 pmRNSHolding(s) in Company
12th Dec 20124:04 pmRNSDirector/PDMR Shareholding
19th Nov 20129:00 amRNSChange of Registered Office
16th Nov 20127:00 amRNSInterim Management Statement
14th Nov 20123:42 pmRNSHolding(s) in Company
13th Nov 20123:35 pmRNSHolding(s) in Company
31st Oct 201212:47 pmRNSHolding(s) in Company
25th Oct 20129:34 amRNSHolding(s) in Company
24th Oct 20124:08 pmRNSHolding(s) in Company
3rd Oct 20129:22 amRNSHolding(s) in Company
13th Aug 20129:34 amRNSHolding(s) in Company
9th Aug 20123:21 pmRNSDirector/PDMR Shareholding
31st Jul 20127:00 amRNSInterim Results
20th Jul 20125:06 pmRNSCompany Secretary Change
13th Jul 20125:05 pmRNSHolding(s) in Company
11th Jul 20123:24 pmRNSBlocklisting Interim Review
6th Jul 20127:00 amRNSNotice of Interim Results
4th Jul 20124:38 pmRNSHolding(s) in Company
28th Jun 20124:45 pmRNSDirector/PDMR Shareholding
26th Jun 20124:58 pmRNSDirector/PDMR Shareholding
23rd May 201212:03 pmRNSAnnual Information Update
22nd May 20122:35 pmRNSDirector/PDMR Shareholding
18th May 20121:53 pmRNSAGM Statement
18th May 201212:30 pmRNSHolding(s) in Company
17th May 20127:00 amRNSInterim Management Statement
16th May 201210:28 amRNSHolding(s) in Company
3rd May 20127:00 amRNSInvestor Seminar
1st May 20129:40 amRNSHolding(s) in Company
26th Apr 20124:38 pmRNSDirector/PDMR Shareholding
17th Apr 20123:17 pmRNSDirector/PDMR Shareholding
3rd Apr 20123:24 pmRNSDirector/PDMR Shareholding
30th Mar 201211:40 amRNSDirector/PDMR Shareholding
22nd Mar 20122:56 pmRNSHolding(s) in Company
21st Mar 20123:05 pmRNSDirector/PDMR Shareholding
20th Mar 20124:59 pmRNSDirector/PDMR Shareholding
20th Mar 201211:41 amRNSHolding(s) in Company
16th Mar 20122:46 pmRNSHolding(s) in Company
15th Mar 20124:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.